{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:42Z","timestamp":1791477942676,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41385-018-0049-9","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T12:01:24Z","timestamp":1529064084000},"page":"1408-1419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma"],"prefix":"10.1016","volume":"11","author":[{"given":"Bart","family":"Hilvering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.C.","family":"Hinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"St\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shrimanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simei","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Thulborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kurioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Bafadhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian B.","family":"Willberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaikalavan","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratko","family":"Djukanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Ogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41385-018-0049-9_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1753465815581279","article-title":"Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma","volume":"9","author":"Hilvering","year":"2015","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1038\/s41385-018-0049-9_bib2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41385-018-0049-9_bib3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41385-018-0049-9_bib4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib5","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1073\/pnas.0914839107","article-title":"Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties","volume":"107","author":"Billerbeck","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/s41385-018-0049-9_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1038\/s41385-018-0049-9_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2013.05.007","article-title":"What is an \u201ceosinophilic phenotype\u201d of asthma?","volume":"132","author":"Nair","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1753465808092281","article-title":"Tissue remodeling and angiogenesis in asthma: the role of the eosinophil","volume":"2","author":"Nissim Ben Efraim","year":"2008","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1038\/s41385-018-0049-9_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41385-018-0049-9_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1038\/s41385-018-0049-9_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.iac.2012.11.002","article-title":"Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease","volume":"33","author":"Mullol","year":"2013","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1038\/s41385-018-0049-9_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41385-018-0049-9_bib14","doi-asserted-by":"crossref","first-page":"L229","DOI":"10.1152\/ajplung.90543.2008","article-title":"CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling","volume":"296","author":"Doherty","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1038\/s41385-018-0049-9_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim","year":"2012","journal-title":"Immunity"},{"key":"10.1038\/s41385-018-0049-9_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaci.2015.06.038","article-title":"Type 2 innate lymphoid cells in induced sputum from children with severe asthma","volume":"137","author":"Nagakumar","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1164\/rccm.200310-1416OC","article-title":"Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma","volume":"171","author":"Cho","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1038\/s41385-018-0049-9_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/ajrccm.164.4.2102018","article-title":"Activated, cytotoxic CD8(+) T lymphocytes contribute to the pathology of asthma death","volume":"164","author":"O'Sullivan","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1038\/s41385-018-0049-9_bib20","unstructured":"Wisniewski, J. A. et al. TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status. J. Allergy Clin. Immunol. pii: S0091-6749(17)31463-X (2017)."},{"key":"10.1038\/s41385-018-0049-9_bib21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.181.3.1229","article-title":"Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia","volume":"181","author":"Coyle","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41385-018-0049-9_bib22","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib23","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.4049\/jimmunol.175.10.6531","article-title":"Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells","volume":"175","author":"Xue","year":"2005","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib24","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.4049\/jimmunol.0804090","article-title":"Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway","volume":"182","author":"Xue","year":"2009","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/all.12451","article-title":"Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459","volume":"69","author":"Pettipher","year":"2014","journal-title":"Allergy"},{"key":"10.1038\/s41385-018-0049-9_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(16)30179-5","article-title":"Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial","volume":"4","author":"Gonem","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1038\/s41385-018-0049-9_bib28","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2014.09.006","article-title":"Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell\/neutrophil crosstalk","volume":"135","author":"Xue","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaci.2016.12.958","article-title":"Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines","volume":"140","author":"Salimi","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaci.2015.01.014","article-title":"Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms","volume":"136","author":"Hinks","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4049\/jimmunol.1102474","article-title":"Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2","volume":"188","author":"Xue","year":"2012","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib32","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.159.9.4593","article-title":"Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation","volume":"159","author":"Lamkhioued","year":"1997","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib33","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI119341","article-title":"Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids","volume":"99","author":"Lilly","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1038\/s41385-018-0049-9_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/cea.12741","article-title":"Elevated levels of circulating CD4(+) CRTh2(+) T cells characterize severe asthma","volume":"46","author":"Palikhe","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"10.1038\/s41385-018-0049-9_bib35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/cea.12758","article-title":"CD8+ T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps","volume":"46","author":"Ma","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"10.1038\/s41385-018-0049-9_bib36","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/all.12311","article-title":"CD8(+) T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseases","volume":"68","author":"Stoeckle","year":"2013","journal-title":"Allergy"},{"key":"10.1038\/s41385-018-0049-9_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaci.2011.08.011","article-title":"Transcriptome analysis shows activation of circulating CD8+T cells in patients with severe asthma","volume":"129","author":"Tsitsiou","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.201512-2452OC","article-title":"A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED","volume":"195","author":"Kuo","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1038\/s41385-018-0049-9_bib39","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.4049\/jimmunol.179.5.2787","article-title":"CD8+ T cell-mediated airway hyperresponsiveness and inflammation is dependent on CD4+IL-4+ T cells","volume":"179","author":"Koya","year":"2007","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10213","article-title":"1,25D3 prevents CD8(+)Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter","volume":"7","author":"Schedel","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1038\/s41385-018-0049-9_bib41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nm1081","article-title":"Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness","volume":"10","author":"Miyahara","year":"2004","journal-title":"Nat. Med."},{"key":"10.1038\/s41385-018-0049-9_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1038\/s41385-018-0049-9_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.it.2004.07.006","article-title":"A role for eosinophils in airway remodelling in asthma","volume":"25","author":"Kay","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib44","first-page":"123s","article-title":"The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma","volume":"13","author":"Frigas","year":"1991","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1038\/s41385-018-0049-9_bib45","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1038\/s41385-018-0049-9_bib46","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/rccm.200306-855OC","article-title":"Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum","volume":"169","author":"Dent","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1038\/s41385-018-0049-9_bib47","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.4049\/jimmunol.163.10.5729","article-title":"Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes","volume":"163","author":"Schwarze","year":"1999","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thx.52.6.513","article-title":"Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4","volume":"52","author":"Sampson","year":"1997","journal-title":"Thorax"},{"key":"10.1038\/s41385-018-0049-9_bib49","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/cea.12654","article-title":"Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma","volume":"45","author":"Mastalerz","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"10.1038\/s41385-018-0049-9_bib50","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/all.12135","article-title":"IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction","volume":"68","author":"Dakhama","year":"2013","journal-title":"Allergy"},{"key":"10.1038\/s41385-018-0049-9_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-2478(94)00223-E","article-title":"Synergism of IL-3, IL-5, and GM-CSF on eosinophil differentiation and its application for an assay of murine IL-5 as an eosinophil differentiation factor","volume":"45","author":"Takamoto","year":"1995","journal-title":"Immunol. Lett."},{"key":"10.1038\/s41385-018-0049-9_bib52","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1399-3038.2009.00908.x","article-title":"The role of TNF-alpha in eosinophilic inflammation associated with RSV bronchiolitis","volume":"21","author":"Choi","year":"2010","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1038\/s41385-018-0049-9_bib53","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1182\/blood-2002-01-0012","article-title":"Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production","volume":"100","author":"Kim","year":"2002","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1038\/s41385-018-0121-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000}}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41385-018-0049-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-018-0049-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922005840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922005840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-018-0049-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T03:31:46Z","timestamp":1675654306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922005840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1933021922005840"],"URL":"https:\/\/doi.org\/10.1038\/s41385-018-0049-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/247171","asserted-by":"object"}]},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41385-018-0049-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/s41385-018-0121-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}